Downregulation of miR-574-5p inhibits HK-2 cell viability and predicts the onset of acute kidney injury in sepsis patients by Shanshan Liu, Lishu Zhao, Li Zhang, Lujun Qiao, Shufang Gao

Get full text

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications by Lishu Zhao, Hao Wang, Kandi Xu, Xinyue Liu, Yayi He, Peifang Wei

Get full text

Efficacy of Naprapathy in Brachial Plexus Injury: Protocol for a Randomized Clinical Trial by Bin Xiao, Lishu Zhao, Yong Huang, Anqi Ma, Baoshun Pei, Zhengyu Li, Fei Gu

Get full text

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment by Peixin Chen, Peixin Chen, Hao Wang, Hao Wang, Lishu Zhao, Lishu Zhao, Haoyue Guo, Haoyue Guo, Liping Zhang, Wei Zhang, Chenglong Sun, Chenglong Sun, Sha Zhao, Sha Zhao, Wei Li, Wei Li, Jun Zhu, Jun Zhu, Jia Yu, Jia Yu, Chunyan Wu, Yayi He, Yayi He

Get full text

Spatial heterogeneity of infiltrating immune cells in the tumor microenvironment of non-small cell lung cancer by Xinyue Liu, Yan Kong, Youwen Qian, Haoyue Guo, Lishu Zhao, Hao Wang, Kandi Xu, Li Ye, Yujin Liu, Hui Lu, Yayi He

Get full text

Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer by Jun Zhu, Hao Wang, Wei Li, Wei Zhang, Liping Zhang, Caicun Zhou, Peixin Chen, Chenglong Sun, Chunyan Wu, Yayi He, Jia Yu, Lishu Zhao, Sha Zhao

Get full text

Correction: T follicular helper cells: linking cancer immunotherapy and immune-related adverse events by Jun Zhu, Hao Wang, Wei Li, Wei Zhang, Liping Zhang, Caicun Zhou, Peixin Chen, Chenglong Sun, Chunyan Wu, Yayi He, Jia Yu, Lishu Zhao, Sha Zhao

Get full text

Noninvasive Immunotyping and Immunotherapy Monitoring of Lung Cancers via Nuclear Imaging of LAG‐3 and PD‐L1 by Lishu Zhao, Jianxian Ge, Ruru Zhang, Hao Wang, Xinyue Liu, Kandi Xu, Yujin Liu, Wencheng Zhao, Wengang Zhang, Li Ye, Zhimin Chen, Jianfeng Zeng, Yayi He, Mingyuan Gao

Get full text

What is the optimal first-line regimen for advanced non-small cell lung cancer patients with epidermal growth factor receptor mutation: a systematic review and network meta-analysi... by Wengang Zhang, Xinyu Zhang, Wencheng Zhao, Zhiyi Guo, Xinyue Liu, Li Ye, Zhimin Chen, Kandi Xu, Yujin Liu, Hao Wang, Lishu Zhao, Qianqian Zhang, Yujie Li, Xuyang Chen, Yayi He

Get full text